Mcrae Capital Management Inc. Purchases 85 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mcrae Capital Management Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,762 shares of the healthcare conglomerate’s stock after purchasing an additional 85 shares during the period. UnitedHealth Group accounts for 2.8% of Mcrae Capital Management Inc.’s investment portfolio, making the stock its 17th biggest position. Mcrae Capital Management Inc.’s holdings in UnitedHealth Group were worth $14,044,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $37,000. Friedenthal Financial bought a new stake in UnitedHealth Group during the third quarter valued at approximately $51,000. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $55,000. Finally, Legacy Investment Solutions LLC purchased a new position in UnitedHealth Group in the third quarter worth $57,000. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Up 0.7 %

Shares of UNH opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market capitalization of $488.95 billion, a price-to-earnings ratio of 34.28, a PEG ratio of 1.45 and a beta of 0.61. The firm’s 50-day moving average price is $524.58 and its 200-day moving average price is $563.71. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.83 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.